BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20546260)

  • 1. Barriers in initiating insulin therapy in a South Asian Muslim community.
    Ahmed US; Junaidi B; Ali AW; Akhter O; Salahuddin M; Akhter J
    Diabet Med; 2010 Feb; 27(2):169-74. PubMed ID: 20546260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.
    Martinez L; Consoli SM; Monnier L; Simon D; Wong O; Yomtov B; Guéron B; Benmedjahed K; Guillemin I; Arnould B
    Health Qual Life Outcomes; 2007 Aug; 5():53. PubMed ID: 17727695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
    Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
    Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group.
    Schiel R; Müller UA; Rauchfub J; Sprott H; Müller R
    Diabetes Metab; 1999 Sep; 25(4):334-40. PubMed ID: 10566123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Initiating insulin therapy in patients with diabetes mellitus type 2: in a transmural setting is at least as effective as in an outpatient setting; a retrospective study with a 4-year follow-up].
    Rosendal H; Vondeling H; de Witte LP; Hutubessy RC; van Beekum WT; Heine RJ
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):166-71. PubMed ID: 11845567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes.
    Franklin VL; Waller A; Pagliari C; Greene SA
    Diabet Med; 2006 Dec; 23(12):1332-8. PubMed ID: 17116184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms of depression and diabetes-specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naïve patients with Type 2 diabetes mellitus. A study from the European Depression in Diabetes [EDID] Research Consortium.
    Makine C; Karşidağ C; Kadioğlu P; Ilkova H; Karşidağ K; Skovlund SE; Snoek FJ; Pouwer F
    Diabet Med; 2009 Jan; 26(1):28-33. PubMed ID: 19125757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin therapy attitudes and beliefs of physicians in Middle Eastern Arab countries.
    Lakkis NA; Maalouf GJ; Mahmassani DM; Hamadeh GN
    Fam Pract; 2013 Oct; 30(5):560-7. PubMed ID: 23729488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to insulin initiation and intensification and how to overcome them.
    Kunt T; Snoek FJ
    Int J Clin Pract Suppl; 2009 Oct; (164):6-10. PubMed ID: 19751453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
    Cooke CE; Lee HY; Tong YP; Haines ST
    Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of glucose-lowering therapy in Type 2 diabetes mellitus patients in general practice.
    Spoelstra JA; Stolk RP; Klungel OH; Erkens JA; Rutten GE; Leufkens HG; Grobbee DE
    Diabet Med; 2004 Aug; 21(8):896-900. PubMed ID: 15270794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
    Meneghini L; Koenen C; Weng W; Selam JL
    Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient.
    Meneghini L
    Int J Clin Pract; 2008 Aug; 62(8):1255-64. PubMed ID: 18705822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study.
    Davis WA; Bruce DG; Davis TM
    Diabetes Care; 2006 Aug; 29(8):1764-70. PubMed ID: 16873777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes in primary care in belgium: need for structured shared care.
    Goderis G; Borgermans L; Heyrman J; Broeke CV; Grol R; Boland B; Mathieu C
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):367-72. PubMed ID: 19358093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a new measure to evaluate psychological resistance to insulin treatment.
    Petrak F; Stridde E; Leverkus F; Crispin AA; Forst T; Pfützner A
    Diabetes Care; 2007 Sep; 30(9):2199-204. PubMed ID: 17575092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
    Valensi P; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Wenying Y;
    Int J Clin Pract; 2009 Mar; 63(3):522-31. PubMed ID: 19187170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.